Literature DB >> 16548584

Lung-surfactant-meconium interaction: in vitro study in bulk and at the air-solution interface.

T Gross1, E Zmora, Y Levi-Kalisman, O Regev, A Berman.   

Abstract

Lung surfactants (LSs) form a monolayer at the lung's alveoli air-solution interface and play a crucial role in making normal breathing possible by reducing the surface tension. LS are affected by various agents that hamper their normal functioning. Tobacco smoke [Bringezu, F.; Pinkerton, K. E.; Zasadzinski, J. A. Langmuir 2003, 19, 2900-2907] and meconium, the first excrement of the newborn, are examples for such LS poison. In neonates, intrauterine aspiration of meconium is a known cause for morbidity and mortality. We studied in vitro the interactions between modified porcine LSs (Curosurf), used as LS replacement, and meconium, as well as between their artificial analogues, phospholipids mixture, and taurocholic acid (TA), respectively. The interactions were examined both in the bulk solution and at the air-water interface, representing the pre- and postnatal situations. It was found that the artificial analogues represent the natural system reliably and exhibit similar effects. TA, a principle component of bile, is an amphiphilic sterol compound in which the hydrophilic and hydrophobic moieties are presented at different faces of the sterol plane. Here we found that TA affects the structure of both monolayers at the interface and surfactant aggregates in solution. A likely poisoning mechanism is by stereoselective penetration of TA into the lamellar or monolayer structures, thus disrupting the contiguous structure of the intact monolayer or the bilayer vesicle structure.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16548584     DOI: 10.1021/la0521241

Source DB:  PubMed          Journal:  Langmuir        ISSN: 0743-7463            Impact factor:   3.882


  4 in total

Review 1.  Meconium-induced inflammation and surfactant inactivation: specifics of molecular mechanisms.

Authors:  Jana Kopincova; Andrea Calkovska
Journal:  Pediatr Res       Date:  2015-12-17       Impact factor: 3.756

2.  Meconium impairs pulmonary surfactant by a combined action of cholesterol and bile acids.

Authors:  Elena Lopez-Rodriguez; Mercedes Echaide; Antonio Cruz; H William Taeusch; Jesus Perez-Gil
Journal:  Biophys J       Date:  2011-02-02       Impact factor: 4.033

3.  Bile acids cause secretory phospholipase A2 activity enhancement, revertible by exogenous surfactant administration.

Authors:  Daniele De Luca; Angelo Minucci; Enrico Zecca; Marco Piastra; Domenico Pietrini; Virgilio P Carnielli; Cecilia Zuppi; Ascanio Tridente; Giorgio Conti; Ettore D Capoluongo
Journal:  Intensive Care Med       Date:  2008-10-14       Impact factor: 17.440

4.  An adverse outcome pathway for lung surfactant function inhibition leading to decreased lung function.

Authors:  Emilie Da Silva; Ulla Vogel; Karin S Hougaard; Jesus Pérez-Gil; Yi Y Zuo; Jorid B Sørli
Journal:  Curr Res Toxicol       Date:  2021-05-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.